Deccan Health Care IPO is all about to make its debut on 18 Dec 2018 with issue size of INR 42.12 cr
Founded in 1996, Deccan Health Care is Hyderabad based firm engaged in developing, manufacturing and marketing of healthcare goods. The company sells premium range nutraceutical, cosmeceutical and Ayurvedic goods under the brand name ‘Be Young’ and ‘Stay Young’.
The Firm offers more than 1,500 goods. These products are used for a variety of things, including immunity boosting, heart health, skin care, and hair care. The company offers a long-chain omega-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune strengthening components, skin ageing treatments, instant energy beverages, and calcium supplements; and a formula for guys. The business offers its products in a number of different formats, including tablets, capsules, gel, liquids, ointments, powder, pastes, etc.
Industry overview
According to a report by Equity Master, the Indian pharmaceuticals market is third in terms of volume and thirteenth in terms of value. It represents 20% in terms of volume and 1.4% in terms of value of the global pharmaceutical industry. India is the world’s largest supplier of generic medications, with Indian generics making up 20% of all global exports in terms of volume. Due to the industry’s extreme fragmentation, consolidation has recently come to represent an important aspect of the Indian pharmaceutical market.
India enjoys an important place in the global pharmaceuticals sector. The country also has a vast pool of scientists and engineers who have the potential to push the business ahead to an even greater level. Currently, Indian pharmaceutical companies provide more than 80% of the antiretroviral medications needed to treat AIDS (Acquired Immuno Deficiency Syndrome) worldwide. The UN-backed Pharmaceuticals Patent Pool has inked six sub-licences with Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, allowing companies to create generic anti-AIDS drug Tenofovir Alafenamide (TAF) for 112 developing countries.
Deccan Health Care IPO Details
| IPO Date | Dec 18, 2018 to Dec 20, 2018 |
| Listing Date | Dec 31, 2018 |
| Face Value | ₹10 per share |
| Price | ₹95 to ₹100 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 4,212,000 shares(aggregating up to ₹42.12 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
Deccan Health Care IPO Tentative Dates
Deccan Health Care IPO opens on Dec 18, 2018, and closes on Dec 20, 2018.
| Event | Tentative Date |
| Opening Date | Dec 18, 2018 |
| Closing Date | Dec 20, 2018 |
| Basis of Allotment | Dec 26, 2018 |
| Initiation of Refunds | Dec 27, 2018 |
| Credit of Shares to Demat | Dec 28, 2018 |
| Listing Date | Dec 31, 2018 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
Company Financials
- Deccan Health Care Financial Summary
| Particulars | For the year/period ended (in Rs. Lakhs) | |||||
| 30-June-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |||
| Total Assets | 6,553.38 | 6,292.99 | 4,959.89 | 2,934.45 | ||
| Total Revenue | 859.35 | 3,976.07 | 2,938.94 | 1,617.70 | ||
| Profit After Tax | 245.81 | 1,268.78 | 953.91 | 354.21 |
Objects of the Issue
The following are the objects of the Fresh Issue’s net proceeds:
1. Repayment or early repayment of some secured loans obtained by the company
2. Acquisition of Plant & Equipment and related civil work
3. General Corporate Purposes.
Deccan Health Care IPO Prospectus
Company Contact Information
Deccan Health Care Limited
247, 2nd floor,
Dwarakapuri Colony,
Punjagutta, Hyderabad – 500082
Phone: +91 040 40144508
Email: investors@deccanhealthcare.co.in
Website: http://www.deccanhealthcare.co.in
Deccan Health Care IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
Deccan Health Care IPO Lead Manager(s)
- Pantomath Capital Advisors Pvt Ltd (Past IPO Performance)
Lead Manager Reports
- IPO Lead Manager Performance Summary
- IPO Lead Manager Performance Tracker
